565 related articles for article (PubMed ID: 21971685)
21. Fully human antibodies against the Protease-Activated Receptor-2 (PAR-2) with anti-inflammatory activity.
Giblin P; Boxhammer R; Desai S; Kroe-Barrett R; Hansen G; Ksiazek J; Panzenbeck M; Ralph K; Schwartz R; Zimmitti C; Pracht C; Miller S; Magram J; Litzenburger T
Hum Antibodies; 2011; 20(3-4):83-94. PubMed ID: 22129678
[TBL] [Abstract][Full Text] [Related]
22. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
Miike S; McWilliam AS; Kita H
J Immunol; 2001 Dec; 167(11):6615-22. PubMed ID: 11714832
[TBL] [Abstract][Full Text] [Related]
23. Protease-activated receptors: the role of cell-surface proteolysis in signalling.
Cottrell GS; Coelho AM; Bunnett NW
Essays Biochem; 2002; 38():169-83. PubMed ID: 12463169
[TBL] [Abstract][Full Text] [Related]
24. Protease-Activated Receptor 2 Facilitates Bacterial Dissemination in Pneumococcal Pneumonia.
van den Boogaard FE; Brands X; Duitman J; de Stoppelaar SF; Borensztajn KS; Roelofs JJTH; Hollenberg MD; Spek CA; Schultz MJ; van 't Veer C; van der Poll T
J Infect Dis; 2018 Apr; 217(9):1462-1471. PubMed ID: 29415278
[TBL] [Abstract][Full Text] [Related]
25. Protease-activated receptor 2 contributes to placental development and fetal growth in mice.
Yamakage S; Oe Y; Sekimoto A; Obata H; Yasuta M; Sato E; Kumakura S; Sato H; Sugawara J; Ito S; Takahashi N
Thromb Res; 2020 Sep; 193():173-179. PubMed ID: 32717642
[TBL] [Abstract][Full Text] [Related]
26. CUX1 transcription factor is a downstream effector of the proteinase-activated receptor 2 (PAR2).
Wilson BJ; Harada R; LeDuy L; Hollenberg MD; Nepveu A
J Biol Chem; 2009 Jan; 284(1):36-45. PubMed ID: 18952606
[TBL] [Abstract][Full Text] [Related]
27. Protease-activated receptors: contribution to physiology and disease.
Ossovskaya VS; Bunnett NW
Physiol Rev; 2004 Apr; 84(2):579-621. PubMed ID: 15044683
[TBL] [Abstract][Full Text] [Related]
28. Constitutive expression of functionally active protease-activated receptors 1 and 2 in human conjunctival epithelial cells.
Nickel TJ; Kabir MH; Talreja J; Stechschulte DJ; Dileepan KN
Mediators Inflamm; 2006; 2006(3):61359. PubMed ID: 16951492
[TBL] [Abstract][Full Text] [Related]
29. Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins.
Sevigny LM; Zhang P; Bohm A; Lazarides K; Perides G; Covic L; Kuliopulos A
Proc Natl Acad Sci U S A; 2011 May; 108(20):8491-6. PubMed ID: 21536878
[TBL] [Abstract][Full Text] [Related]
30. Protease-activated receptor-2 (PAR2) in the airways.
Cocks TM; Moffatt JD
Pulm Pharmacol Ther; 2001; 14(3):183-91. PubMed ID: 11448145
[TBL] [Abstract][Full Text] [Related]
31. Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy.
Oe Y; Hayashi S; Fushima T; Sato E; Kisu K; Sato H; Ito S; Takahashi N
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1525-33. PubMed ID: 27283743
[TBL] [Abstract][Full Text] [Related]
32. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
33. PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.
McCoy KL; Traynelis SF; Hepler JR
Mol Pharmacol; 2010 Jun; 77(6):1005-15. PubMed ID: 20215560
[TBL] [Abstract][Full Text] [Related]
34. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins.
Jacob C; Yang PC; Darmoul D; Amadesi S; Saito T; Cottrell GS; Coelho AM; Singh P; Grady EF; Perdue M; Bunnett NW
J Biol Chem; 2005 Sep; 280(36):31936-48. PubMed ID: 16027150
[TBL] [Abstract][Full Text] [Related]
35. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway.
Schmidlin F; Amadesi S; Dabbagh K; Lewis DE; Knott P; Bunnett NW; Gater PR; Geppetti P; Bertrand C; Stevens ME
J Immunol; 2002 Nov; 169(9):5315-21. PubMed ID: 12391252
[TBL] [Abstract][Full Text] [Related]
36. The role of protease-activated receptor type 2 in nociceptive signaling and pain.
Mrozkova P; Palecek J; Spicarova D
Physiol Res; 2016 Jul; 65(3):357-67. PubMed ID: 27070742
[TBL] [Abstract][Full Text] [Related]
37. Protease-activated receptors: regulation of neuronal function.
Saito T; Bunnett NW
Neuromolecular Med; 2005; 7(1-2):79-99. PubMed ID: 16052040
[TBL] [Abstract][Full Text] [Related]
38. Modulation of expression of innate immunity markers CXCL5/ENA-78 and CCL20/MIP3alpha by protease-activated receptors (PARs) in human gingival epithelial cells.
Rohani MG; Beyer RP; Hacker BM; Dommisch H; Dale BA; Chung WO
Innate Immun; 2010 Apr; 16(2):104-14. PubMed ID: 19567485
[TBL] [Abstract][Full Text] [Related]
39. Tissue factor pathways linking obesity and inflammation.
Ruf W; Samad F
Hamostaseologie; 2015; 35(3):279-83. PubMed ID: 25623940
[TBL] [Abstract][Full Text] [Related]
40. Evolution of primary hemostasis in early vertebrates.
Kim S; Carrillo M; Kulkarni V; Jagadeeswaran P
PLoS One; 2009 Dec; 4(12):e8403. PubMed ID: 20037653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
